COVID-19

RT-PCR Testing

Appointments are available, but not required — please call 1-800-960-1080 to make an appointment.

Test results: 24 hours or less

Test price: $125

  • Acceptable for most travel requirements—know your travel requirements prior to testing, KSL Diagnostics does NOT take responsibility for travel testing requirements beyond providing test results in 24 hours or less

  • Positive results indicate an individual is currently infected with COVID-19 

  • Specimens are collected by oropharyngeal, nasopharyngeal, or anterior nares swab

  • Payment not required with valid doctor's prescription

  • For more information on KSL Diagnostics test pricing and policies, see below or call 1-800-960-1080 to speak with a representative.
  • Meets requirement for NAAT (nucleic acid amplification test)

COVID-19 Travel Testing:

At KSL Diagnostics, we understand COVID-19 travel testing requires urgent and special attention to ensure your test results are valid when traveling across state lines or to another country. To assist you with your travel testing needs:

  • Receive same day test results by midnight (12 am) for COVID-19 RT-PCR tests collected before 3 pm

  • Receive next day results by noon (12 pm) for COVID-19 RT-PCR tests collected after 3 pm

 

Send your specific travel testing questions to info@ksldx.com — we regularly monitor this account and will respond promptly.

Significance of this test:

 

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously called 2019-nCoV) belongs to the family of coronaviruses and, like SARS-CoV, is classified in the genus Betacoronavirus [1]. The new coronavirus originated in China in the city of Wuhan, Hubei province. It caused an infection wave, which has spread rapidly within the country and worldwide [2, 3]. Just a few days after the first report about patients with pneumonia of unclear origin, the causative pathogen was identified as SARS-CoV-2 [2-4].

SARS-CoV-2 is predominantly transmitted by droplet infection via coughing or sneezing and through close contact with infected patients [2, 3, 5].

 

The incubation time of SARS-CoV is three to seven, maximally 14 days [2]. The symptoms of SARS-CoV-2 infection are fever, coughing, breathing difficulties and fatigue [2, 3, 5]. In most patients the infection manifests with symptoms of a mild febrile illness with irregular lung infiltrates. Some patients, especially elderly or chronically ill patients, develop severe acute respiratory distress syndrome (ARDS). The disease is fatal in around 3% of cases [2, 3, 5]. In February 2020, the disease caused by SARS-CoV-2 was named COVID-19 by the WHO.

 

COVID-19 RT-PCR test is a reverse transcription polymerase chain reaction test to detect SARS-CoV-2, the virus that causes COVID-19.

Frequently Asked Questions

What is a COVID-19 RT-PCR test?


  • A COVID-19 virus test is a RT-PCR test that detects RNA that is unique to the SARS-CoV-2 virus. The specimen for this testing is generally collected using a oropharyngeal swab unless a nasopharyngeal swab is requested. COVID-19 virus test results are positive during infection (asymptomatic or symptomatic) and negative for individuals who have not been infected as well as in individuals who have been infected but whose immune system has effectively cleared the virus.




What is RT-PCR?


  • RT-PCR stands for Reverse Transcription Polymerase Chain Reaction, a laboratory method used to detect specific RNA sequences. This is a high sensitivity laboratory method that utilizes polymerase to amplify specific genetic targets. Amplification is monitored and indicative of the presence of the target if amplification is successful. RT-PCR generally produces results within a few hours.




What is SARS-CoV-2?


  • SARS-CoV-2 is the abbreviation for Severe Acute Respiratory Syndrome Coronavirus 2, the virus that caused coronavirus disease-2019, also known as COVID-19 or novel coronavirus disease.




What can my COVID-19 test results tell me?


  • Consult this table for basic interpretation of results. This is a guide. Please consult your healthcare provider assistance with your diagnosis and more detailed information.




How much does the test cost and who pays for it?


  • KSL Diagnostics is not a government-funded testing facility and the testing is NOT free. The cost for COVID-19 Virus Testing by RT-PCR (CPT Code U0004) or COVID-19 IgG, IgM, IgA Antibody Testing by CLIA (CPT Codes 86769 x3) is $100 per test, plus $25 for specimen collection ($125 total for each test). Testing may be covered by private insurance, Medicaid, Medicare and other governmental reimbursers.If you have a prescription, there is no upfront charge. If you do not have a prescription, KSL Diagnostics will provide you with a receipt for your test so that you may submit it to your insurance company for possible reimbursement. If you have specific questions, please call KSL at 1-800-960-1080 to speak with a representative.




Does insurance cover this test?


  • Insurance will generally cover testing for patients with suspected COVID-19 exposure and symptoms consistent with COVID-19, or patients requiring a test for surgical procedures. Insurance will generally NOT cover for all other COVID-19 testing needs—including travel and elective COVID-19 testing.




Are these tests approved by FDA?


  • The COVID-19 tests currently offered by KSL are approved by FDA through Emergency Use Authorization (EUA).





References:

 

  1. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv preprint. doi: 10.1101/2020.02.07.937862

  2. Wang G, Jin X. The progress of 2019 Novel Coronavirus (2019-nCoV) event in China. J MedVirol. doi: 10.1002/jmv.25705

  3. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses 2020, 12(2), 135

  4. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3): pii=2000045

  5. Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring. J Med Virol. 2020; 1-4

 
var openWidget = function() { document.getElementById('fc_frame').style.visibility = 'visible'; window.fcWidget.open(); };